Skip to main content

Table 4 Percentages of the mutated genes in patients with BCC from different studies

From: Molecular profiling of basal cell carcinomas in young patients

Different studies PTCH1 TP53 SMO RB1 MYCN
Reifenberger et al. [14] 50–85%     
Jayaraman et al. [15] 75% 66%
Bonilla et al. [13] 73% 61% 20% < 1% 30%
Maturo et al. [16] 59% 31%    
Our study 64% 21% 11% 7% 4%